- $34.22m
- -$17.65m
- $1.68m
- 18
- 25
- 21
- 10
Annual income statement for Akili, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 3.94 | 0.538 | 0.323 | 1.68 |
| Cost of Revenue | ||||
| Gross Profit | 3.52 | 0.183 | -0.118 | 0.859 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 29.4 | 61.4 | 91 | 66.2 |
| Operating Profit | -25.4 | -60.9 | -90.7 | -64.5 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -25.6 | -61.3 | -7.95 | -59.4 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -25.6 | -61.3 | -7.96 | -59.5 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -25.6 | -61.3 | -7.96 | -59.5 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -25.6 | -127 | -19 | -59.5 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.329 | -1.62 | -0.244 | -0.758 |